- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SCIO-469 and bortezomib
Total 1192 results
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
University Hospital of CreteCompletedNon Small Cell Lung Cancer | MetastaticGreece
-
Cancer Trials IrelandCompleted
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
University of ChicagoRecruiting
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
University of ArkansasWithdrawn
-
Janssen-Cilag G.m.b.HCompleted
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Qilu Hospital of Shandong University and other collaboratorsRecruitingT-cell Lymphoblastic LymphomaChina
-
Guangdong Provincial People's HospitalRecruitingImmunoglobulin Light-Chain AmyloidosisChina
-
University of Heidelberg Medical CenterSanofi; KKS Netzwerk; Deutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
University of Heidelberg Medical CenterJanssen Research & Development, LLC; Deutsche Studiengruppe Multiples Myelom...Recruiting
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
TakedaActive, not recruiting
-
Indiana UniversityWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia, Adult | Bone Marrow Transplant ComplicationsUnited States
-
Massachusetts General HospitalBristol-Myers Squibb; Celgene; Multiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Merck Sharp & Dohme LLCCompleted
-
University of ArkansasWithdrawn
-
University of MiamiTerminatedLymphoma | Follicular Lymphoma | Marginal Zone LymphomaUnited States
-
Ruijin HospitalUnknownDiffuse Large B-cell LymphomaChina
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Janssen-Cilag G.m.b.HCompleted
-
University of ArkansasMillennium Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLymphoma, Mantle-CellTaiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Ankara UniversityCompletedOsteoporosis RiskTurkey
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
NantCell, Inc.CompletedBreast Cancer | Metastatic Cancer | Breast TumorsUnited States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Janssen-Cilag Farmaceutica Ltda.Completed
-
National University of Ireland, Galway, IrelandJanssen Pharmaceuticals; Cancer Trials IrelandUnknownMultiple MyelomaIreland
-
PETHEMA FoundationCompleted
-
Dana-Farber Cancer InstituteCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
University of MiamiWithdrawnMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Mantle Cell LymphomaUnited States
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
Karyopharm Therapeutics IncRecruiting
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
Sumitomo Pharma America, Inc.CompletedHematologic MalignancyUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Henrik GregersenUnknown
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
Memorial Sloan Kettering Cancer CenterBrigham and Women's Hospital; Weill Medical College of Cornell University; The... and other collaboratorsCompletedBreast Cancer | Cognitive Side Effects of Cancer Treatments | Stage I, II and III A Breast CancerUnited States
-
Janssen Research & Development, LLCRecruitingAmyloidosisCanada, Italy, United States, Greece, China, Netherlands, Spain, France, Germany, United Kingdom